Hydroksyklorokin (Norwegian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hydroksyklorokin" in Norwegian language version.

refsWebsite

Global rank Norwegian rank

11doi.org

2^nd place

9^th place

11nih.gov

4^th place

23^rd place

4web.archive.org

1^st place

3isac.world

low place

2felleskatalogen.no

low place

318^th place

2sciencedirect.com

149^th place

236^th place

2retractionwatch.com

low place

2clinicaltrials.gov

5,225^th place

9,018^th place

1archive.today

14^th place

37^th place

1drugs.com

399^th place

2,066^th place

1legemiddelhandboka.no

low place

674^th place

1nytimes.com

7^th place

33^rd place

1wikidata.org

43^rd place

11^th place

1oup.com

485^th place

429^th place

1clincalc.com

3,912^th place

low place

1pdr.net

low place

1webmd.com

1,169^th place

2,623^rd place

1relis.no

low place

6,320^th place

1ashp.org

low place

1cdc.gov

218^th place

639^th place

1fda.gov

447^th place

2,058^th place

1hopkinsguides.com

low place

1scienceintegritydigest.com

low place

1politico.com

312^th place

1,242^nd place

1legifrance.gouv.fr

265^th place

295^th place

1sciencemag.org

857^th place

279^th place

1worldcat.org

5^th place

13^th place

1recoverytrial.net

low place

1dagbladet.no

1,677^th place

6^th place

1lmi.no

low place

1vg.no

1,177^th place

4^th place

archive.today

«Plaquenil «sanofi-aventis» - Felleskatalogen». www.felleskatalogen.no. Felleskatalogen. 8. april 2020. Arkivert fra originalen 8. april 2020. Besøkt 8. april 2020. «Legemiddel underlagt rasjonering i forbindelse med COVID-19 … Varsel fra Legemiddelverket: Rasjonering av Plaquenil Type: Generelt Publisert første gang: 30.03.2020 Plaquenil er underlagt rasjonering fra apotek til pasient. Plaquenil og tilvarende kan kun leveres ut på blå resept. … 200 mg: Hver tablett inneh.: Hydroksyklorokinsulfat 200 mg tilsv. hydroksyklorokin 155 mg,»

ashp.org

«Assessment of Evidence for COVID-19-Related Treatments: Updated 4/3/2020». ASHP. Arkivert fra originalen 14. april 2021. Besøkt 7. april 2020.

cdc.gov

«Coronavirus Disease 2019 (COVID-19)». Centers for Disease Control and Prevention (engelsk). 11. februar 2020. Besøkt 9. april 2020.

clincalc.com

«The Top 300 of 2020». ClinCalc. Besøkt 18. mars 2020.

clinicaltrials.gov

«Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)». ClinicalTrials.gov. 3. april 2020. Besøkt 11. april 2020.
«The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients - Full Text View - ClinicalTrials.gov». clinicaltrials.gov (engelsk). Besøkt 20. mai 2020.

dagbladet.no

Kvaale, Vegard Kristiansen (20. mars 2020). ««Trump-medisinen» skal testes i Norge». Dagbladet.no (norsk). Besøkt 25. mai 2020.

doi.org

«A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19». Journal of Critical Care. mars 2020. PMID 32173110. doi:10.1016/j.jcrc.2020.03.005.
Mandeep R. Mehra; Sapan S Desai; Frank Ruschitzka; Amit N Patel (22. mai 2020). «Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis». The Lancet. PMC 7255293 . PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. Wikidata Q95177432.
«BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids». Rheumatology. 55 (9): 1693–7. september 2016. PMID 26750124. doi:10.1093/rheumatology/kev404. CS1-vedlikehold: vis-forfattere (link)
«Hydroxychloroquine in dermatology: New perspectives on an old drug». The Australasian Journal of Dermatology. oktober 2019. PMID 31612996. doi:10.1111/ajd.13168.
«Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis». BMC Musculoskeletal Disorders. 18 (1): 186. mai 2017. PMC 5427554 . PMID 28499370. doi:10.1186/s12891-017-1543-z.
«Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis». Arthritis and Rheumatism. 54 (10): 3079–86. oktober 2006. PMID 17009226. doi:10.1002/art.22131.
«Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence». BMJ. 368: m1166. Mars 2020. PMID 32205321. doi:10.1136/bmj.m1166.
«Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics». JAMA. Mars 2020. PMID 32208486. doi:10.1001/jama.2020.4742.
Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Mailhe, Morgane; Doudier, Barbara; Courjon, Johan; Giordanengo, Valérie; Vieira, Vera Esteves; Dupont, Hervé Tissot (20. mars 2020). «Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial». International Journal of Antimicrobial Agents: 105949. PMC 7102549 . PMID 32205204. doi:10.1016/j.ijantimicag.2020.105949.
Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Mailhe, Morgane; Doudier, Barbara; Courjon, Johan; Giordanengo, Valérie; Vieira, Vera Esteves; Dupont, Hervé Tissot (20. mars 2020). «Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial». International Journal of Antimicrobial Agents: 105949. doi:10.1016/j.ijantimicag.2020.105949.
Boulware, David R.; Pullen, Matthew F.; Bangdiwala, Ananta S.; Pastick, Katelyn A.; Lofgren, Sarah M.; Okafor, Elizabeth C.; Skipper, Caleb P.; Nascene, Alanna A.; Nicol, Melanie R. (3. juni 2020). «A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19». New England Journal of Medicine. 0. 0: null. ISSN 0028-4793. doi:10.1056/NEJMoa2016638. Besøkt 5. juni 2020.

drugs.com

«Hydroxychloroquine Sulfate Monograph for Professionals». The American Society of Health-System Pharmacists. 20. mars 2020. Arkivert fra originalen 20. mars 2020. Besøkt 20. mars 2020.

fda.gov

«FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems». FDA. 24. april 2020.

felleskatalogen.no

«Plaquenil «sanofi-aventis» - Felleskatalogen». www.felleskatalogen.no. Felleskatalogen. 8. april 2020. Arkivert fra originalen 8. april 2020. Besøkt 8. april 2020. «Legemiddel underlagt rasjonering i forbindelse med COVID-19 … Varsel fra Legemiddelverket: Rasjonering av Plaquenil Type: Generelt Publisert første gang: 30.03.2020 Plaquenil er underlagt rasjonering fra apotek til pasient. Plaquenil og tilvarende kan kun leveres ut på blå resept. … 200 mg: Hver tablett inneh.: Hydroksyklorokinsulfat 200 mg tilsv. hydroksyklorokin 155 mg,»
«Plaquenil «sanofi-aventis» - Felleskatalogen». www.felleskatalogen.no. Besøkt 20. mai 2020.

hopkinsguides.com

«Hydroxychloroquine | Johns Hopkins ABX Guide». www.hopkinsguides.com (engelsk). Besøkt 24. april 2020.

isac.world

Media, M. T. C. «Statement on IJAA paper | International Society of Antimicrobial Chemotherapy». www.isac.world (engelsk). Besøkt 13. april 2020.
Media, M. T. C. «International Journal of Antimicrobial Agents | International Society of Antimicrobial Chemotherapy». www.isac.world (engelsk). Besøkt 13. april 2020.
Media, M. T. C. «Joint ISAC and Elsevier statement on Gautret et al. paper [PMID 32205204]». www.isac.world. Besøkt 13. april 2020.

legemiddelhandboka.no

«Legemiddelhåndboka». www.legemiddelhandboka.no. Besøkt 20. mai 2020.

legifrance.gouv.fr

«Décret n° 2020-630 du 26 mai 2020 modifiant le décret n° 2020-548 du 11 mai 2020 prescrivant les mesures générales nécessaires pour faire face à l'épidémie de covid-19 dans le cadre de l'état d'urgence sanitaire». 26. mai 2020. Besøkt 27. mai 2020.

lmi.no

«Salg av malariamedisinen Hydroksyklorokin øker 60 prosent». Legemiddelindustrien. 12. mai 2020. Besøkt 25. mai 2020.

nih.gov

ncbi.nlm.nih.gov

«A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19». Journal of Critical Care. mars 2020. PMID 32173110. doi:10.1016/j.jcrc.2020.03.005.
Mandeep R. Mehra; Sapan S Desai; Frank Ruschitzka; Amit N Patel (22. mai 2020). «Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis». The Lancet. PMC 7255293 . PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. Wikidata Q95177432.
«BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids». Rheumatology. 55 (9): 1693–7. september 2016. PMID 26750124. doi:10.1093/rheumatology/kev404. CS1-vedlikehold: vis-forfattere (link)
«Hydroxychloroquine in dermatology: New perspectives on an old drug». The Australasian Journal of Dermatology. oktober 2019. PMID 31612996. doi:10.1111/ajd.13168.
«Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis». BMC Musculoskeletal Disorders. 18 (1): 186. mai 2017. PMC 5427554 . PMID 28499370. doi:10.1186/s12891-017-1543-z.
«Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis». Arthritis and Rheumatism. 54 (10): 3079–86. oktober 2006. PMID 17009226. doi:10.1002/art.22131.
«Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence». BMJ. 368: m1166. Mars 2020. PMID 32205321. doi:10.1136/bmj.m1166.
«Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics». JAMA. Mars 2020. PMID 32208486. doi:10.1001/jama.2020.4742.
Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Mailhe, Morgane; Doudier, Barbara; Courjon, Johan; Giordanengo, Valérie; Vieira, Vera Esteves; Dupont, Hervé Tissot (20. mars 2020). «Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial». International Journal of Antimicrobial Agents: 105949. PMC 7102549 . PMID 32205204. doi:10.1016/j.ijantimicag.2020.105949.

dailymed.nlm.nih.gov

«Plaquenil- hydroxychloroquine sulfate tablet». DailyMed. 3. januar 2020. Besøkt 20. mars 2020.

nih.gov

«NIH clinical trial of hydroxychloroquine, a potential therapy for COVID-19, begins» (pressemelding). 9. april 2020.

nytimes.com

Grady, Denise (1. april 2020). «Malaria Drug Helps Virus Patients Improve, in Small Study». The New York Times. Arkivert fra originalen 1. april 2020. Besøkt 1. april 2020.

oup.com

academic.oup.com

«BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids». Rheumatology. 55 (9): 1693–7. september 2016. PMID 26750124. doi:10.1093/rheumatology/kev404. CS1-vedlikehold: vis-forfattere (link)

pdr.net

«Plaquenil (hydroxychloroquine sulfate) dose, indications, adverse effects, interactions». pdr.net. Besøkt 19. mars 2020.

politico.com

Braun, Elisa. «France bans use of hydroxychloroquine to cure coronavirus». POLITICO (engelsk). Besøkt 27. mai 2020.

recoverytrial.net

«No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19» (PDF) (pressemelding). RECOVERY. 4. juni 2020. «We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19. We have therefore decided to stop enrolling participants to the hydroxychloroquine arm of the RECOVERY trial with immediate effect. We are now releasing the preliminary results as they have important implications for patient care and public health.»

relis.no

«Dokumentasjon for bruk av hydroksyklorokin ved COVID-19». www.relis.no (norsk). Arkivert fra originalen 20. mai 2020. Besøkt 20. mai 2020.

retractionwatch.com

Marcus, Author Adam (6. april 2020). «Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”». Retraction Watch (engelsk). Besøkt 13. april 2020.
Marcus, Author Adam (12. april 2020). «Elsevier investigating hydroxychloroquine-COVID-19 paper». Retraction Watch (engelsk). Besøkt 13. april 2020.

sciencedirect.com

«A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19». Journal of Critical Care. mars 2020. PMID 32173110. doi:10.1016/j.jcrc.2020.03.005.
Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Mailhe, Morgane; Doudier, Barbara; Courjon, Johan; Giordanengo, Valérie; Vieira, Vera Esteves; Dupont, Hervé Tissot (20. mars 2020). «Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial». International Journal of Antimicrobial Agents: 105949. doi:10.1016/j.ijantimicag.2020.105949.

scienceintegritydigest.com

eliesbik, Author (24. mars 2020). «Thoughts on the Gautret et al. paper about Hydroxychloroquine and Azithromycin treatment of COVID-19 infections». Science Integrity Digest (engelsk). Besøkt 13. april 2020.

sciencemag.org

Piller, Charles; ServickJun. 4, Kelly; 2020; Pm, 5:30 (4. juni 2020). «Two elite medical journals retract coronavirus papers over data integrity questions». Science | AAAS (engelsk). Besøkt 5. juni 2020.

vg.no

«Donald Trump: – Jeg bruker hydroksyklorokin». www.vg.no. Besøkt 25. mai 2020.

web.archive.org

«Hydroxychloroquine Sulfate Monograph for Professionals». The American Society of Health-System Pharmacists. 20. mars 2020. Arkivert fra originalen 20. mars 2020. Besøkt 20. mars 2020.
Grady, Denise (1. april 2020). «Malaria Drug Helps Virus Patients Improve, in Small Study». The New York Times. Arkivert fra originalen 1. april 2020. Besøkt 1. april 2020.
«Dokumentasjon for bruk av hydroksyklorokin ved COVID-19». www.relis.no (norsk). Arkivert fra originalen 20. mai 2020. Besøkt 20. mai 2020.
«Assessment of Evidence for COVID-19-Related Treatments: Updated 4/3/2020». ASHP. Arkivert fra originalen 14. april 2021. Besøkt 7. april 2020.

webmd.com

«Drugs & Medications». webmd.com. Besøkt 19. mars 2020.

wikidata.org

Mandeep R. Mehra; Sapan S Desai; Frank Ruschitzka; Amit N Patel (22. mai 2020). «Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis». The Lancet. PMC 7255293 . PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. Wikidata Q95177432.

worldcat.org

Boulware, David R.; Pullen, Matthew F.; Bangdiwala, Ananta S.; Pastick, Katelyn A.; Lofgren, Sarah M.; Okafor, Elizabeth C.; Skipper, Caleb P.; Nascene, Alanna A.; Nicol, Melanie R. (3. juni 2020). «A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19». New England Journal of Medicine. 0. 0: null. ISSN 0028-4793. doi:10.1056/NEJMoa2016638. Besøkt 5. juni 2020.